Skip to content

Press Release · Press Releases

Dr. Bobak Parang Announced as Recipient of Rising Tide/LUNGevity Research Award for Overcoming Drug Resistance

Issued by PR Newswire

Image: PR Newswire

$600K+ investment leverages combination of FDA approved treatments to overcome drug resistance in EGFR-positive lung cancer WASHINGTON, Oct. 28, 2026 /PRNewswire/ -- A groundbreaking clinical trial aimed at overcoming drug resistance in EGFR-positive non-small cell lung cancer (NSCLC),...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

Vertiv Reports Strong Third Quarter 2026 with Net Sales Growth of 61%, Organic Orders Growth over 100% and Diluted EPS Growth of 91% (Adjusted Diluted EPS Growth of 78%); Raises Full Year 2026 Guidance Across All Key Metrics

Third Quarter 2026 Results Net sales of $4,313 million, 61% higher than third quarter 2025. Operating profit up 90% and adjusted operating profit(1) up 83% from third quarter 2025. Adjusted operating margin of 25.2%, up 290 basis points compared to third quarter 2025. Diluted EPS grew 91%...

PR Newswire ·

Press Release

OppFi Reports Third Quarter 2026 Results

Launched new Line of Credit product, representing a significant milestone in the expansion of OppFi's product suite Continued execution of product and pricing initiatives designed to expand addressable market opportunities and enhance customer choice Repurchased $6.7 million of common...

PR Newswire ·